Silver nanoparticles composition for treatment of distemper in dogs

Nina Bogdanchikova, Roberto Vázquez-Muñoz, Alejandro Huerta-Saquero, Antonio Pena-Jasso, Gildardo Aguilar-Uzcanga, Paola L. Picos-Díaz, Alexey Pestryakov, Vasilii Burmistrov, Oxana Anatolievna Martynyuk, Roberto Luna-Vazquez-Gomez, Horacio Almanza

Research School of Chemistry & Applied Biomedical Sciences

Research output: Contribution to journal › Article

7 Citations (Scopus)

Abstract

Canine distemper is caused by the canine distemper virus (CDV), a paramyxovirus of the genus Morbillivirus, with a worldwide distribution. Canine distemper is a multisystem disease, potentially fatal. Affected organisms may develop clinical or subclinical infections, among them respiratory, gastrointestinal and of the nervous system. In the present work, we use a veterinary pharmaceutical composition of silver nanoparticles (AgNPs) for the treatment of distemper in dogs with neurological and nonneurological symptoms. AgNPs treatment of animals with non-neurological distemper provides a very high rate of recovery without sequelae. However, in dogs with neurological symptoms, AgNPs treatment was not able to reverse the disease.

Original language	English
Pages (from-to)	227-237
Number of pages	11
Journal	International Journal of Nanotechnology
Volume	13
Issue number	1-3
DOIs	https://doi.org/10.1504/IJNT.2016.074536
Publication status	Published - 2016

Fingerprint

Keywords

AgNPs treatment
Canine distemper virus
CDV
Distemper virus
Silver nanoparticles

ASJC Scopus subject areas

Electrical and Electronic Engineering
Materials Chemistry
Condensed Matter Physics
Bioengineering

Cite this

Bogdanchikova, N., Vázquez-Muñoz, R., Huerta-Saquero, A., Pena-Jasso, A., Aguilar-Uzcanga, G., Picos-Díaz, P. L., Pestryakov, A., Burmistrov, V., Martynyuk, O. A., Luna-Vazquez-Gomez, R., & Almanza, H. (2016). Silver nanoparticles composition for treatment of distemper in dogs. International Journal of Nanotechnology, 13(1-3), 227-237. https://doi.org/10.1504/IJNT.2016.074536

Silver nanoparticles composition for treatment of distemper in dogs. / Bogdanchikova, Nina; Vázquez-Muñoz, Roberto; Huerta-Saquero, Alejandro; Pena-Jasso, Antonio; Aguilar-Uzcanga, Gildardo; Picos-Díaz, Paola L.; Pestryakov, Alexey; Burmistrov, Vasilii; Martynyuk, Oxana Anatolievna; Luna-Vazquez-Gomez, Roberto; Almanza, Horacio.

In: International Journal of Nanotechnology, Vol. 13, No. 1-3, 2016, p. 227-237.

Research output: Contribution to journal › Article

Bogdanchikova, N, Vázquez-Muñoz, R, Huerta-Saquero, A, Pena-Jasso, A, Aguilar-Uzcanga, G, Picos-Díaz, PL, Pestryakov, A, Burmistrov, V, Martynyuk, OA, Luna-Vazquez-Gomez, R & Almanza, H 2016, 'Silver nanoparticles composition for treatment of distemper in dogs', International Journal of Nanotechnology, vol. 13, no. 1-3, pp. 227-237. https://doi.org/10.1504/IJNT.2016.074536

Bogdanchikova, Nina ; Vázquez-Muñoz, Roberto ; Huerta-Saquero, Alejandro ; Pena-Jasso, Antonio ; Aguilar-Uzcanga, Gildardo ; Picos-Díaz, Paola L. ; Pestryakov, Alexey ; Burmistrov, Vasilii ; Martynyuk, Oxana Anatolievna ; Luna-Vazquez-Gomez, Roberto ; Almanza, Horacio. / Silver nanoparticles composition for treatment of distemper in dogs. In: International Journal of Nanotechnology. 2016 ; Vol. 13, No. 1-3. pp. 227-237.

@article{d326dce56aeb4a4bbf15bdf20d9aed6e,

title = "Silver nanoparticles composition for treatment of distemper in dogs",

abstract = "Canine distemper is caused by the canine distemper virus (CDV), a paramyxovirus of the genus Morbillivirus, with a worldwide distribution. Canine distemper is a multisystem disease, potentially fatal. Affected organisms may develop clinical or subclinical infections, among them respiratory, gastrointestinal and of the nervous system. In the present work, we use a veterinary pharmaceutical composition of silver nanoparticles (AgNPs) for the treatment of distemper in dogs with neurological and nonneurological symptoms. AgNPs treatment of animals with non-neurological distemper provides a very high rate of recovery without sequelae. However, in dogs with neurological symptoms, AgNPs treatment was not able to reverse the disease.",

keywords = "AgNPs treatment, Canine distemper virus, CDV, Distemper virus, Silver nanoparticles",

author = "Nina Bogdanchikova and Roberto V{\'a}zquez-Mu{\~n}oz and Alejandro Huerta-Saquero and Antonio Pena-Jasso and Gildardo Aguilar-Uzcanga and Picos-D{\'i}az, {Paola L.} and Alexey Pestryakov and Vasilii Burmistrov and Martynyuk, {Oxana Anatolievna} and Roberto Luna-Vazquez-Gomez and Horacio Almanza",

year = "2016",

doi = "10.1504/IJNT.2016.074536",

language = "English",

volume = "13",

pages = "227--237",

journal = "International Journal of Nanotechnology",

issn = "1475-7435",

publisher = "Inderscience Enterprises Ltd",

number = "1-3",

}

TY - JOUR

T1 - Silver nanoparticles composition for treatment of distemper in dogs

AU - Bogdanchikova, Nina

AU - Vázquez-Muñoz, Roberto

AU - Huerta-Saquero, Alejandro

AU - Pena-Jasso, Antonio

AU - Aguilar-Uzcanga, Gildardo

AU - Picos-Díaz, Paola L.

AU - Pestryakov, Alexey

AU - Burmistrov, Vasilii

AU - Martynyuk, Oxana Anatolievna

AU - Luna-Vazquez-Gomez, Roberto

AU - Almanza, Horacio

PY - 2016

Y1 - 2016

N2 - Canine distemper is caused by the canine distemper virus (CDV), a paramyxovirus of the genus Morbillivirus, with a worldwide distribution. Canine distemper is a multisystem disease, potentially fatal. Affected organisms may develop clinical or subclinical infections, among them respiratory, gastrointestinal and of the nervous system. In the present work, we use a veterinary pharmaceutical composition of silver nanoparticles (AgNPs) for the treatment of distemper in dogs with neurological and nonneurological symptoms. AgNPs treatment of animals with non-neurological distemper provides a very high rate of recovery without sequelae. However, in dogs with neurological symptoms, AgNPs treatment was not able to reverse the disease.

AB - Canine distemper is caused by the canine distemper virus (CDV), a paramyxovirus of the genus Morbillivirus, with a worldwide distribution. Canine distemper is a multisystem disease, potentially fatal. Affected organisms may develop clinical or subclinical infections, among them respiratory, gastrointestinal and of the nervous system. In the present work, we use a veterinary pharmaceutical composition of silver nanoparticles (AgNPs) for the treatment of distemper in dogs with neurological and nonneurological symptoms. AgNPs treatment of animals with non-neurological distemper provides a very high rate of recovery without sequelae. However, in dogs with neurological symptoms, AgNPs treatment was not able to reverse the disease.

KW - AgNPs treatment

KW - Canine distemper virus

KW - CDV

KW - Distemper virus

KW - Silver nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84958748338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958748338&partnerID=8YFLogxK

U2 - 10.1504/IJNT.2016.074536

DO - 10.1504/IJNT.2016.074536

M3 - Article

AN - SCOPUS:84958748338

VL - 13

SP - 227

EP - 237

JO - International Journal of Nanotechnology

JF - International Journal of Nanotechnology

SN - 1475-7435

IS - 1-3

ER -

Access to Document

10.1504/IJNT.2016.074536